학술논문
Thioguanine Combined with Decitabine Can Overcome Resistance to Hypomethylating Agents: Final Results of a Phase I Trial of a Pharmacodynamically-Conceived Thioguanine/Decitabine Combination in Patients with Advanced Myeloid Malignancies
Document Type
Abstract
Author
Source
In Blood 2 December 2016 128(22):2816-2816
Subject
Language
ISSN
0006-4971